Compare NKTR & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTR | UPBD |
|---|---|---|
| Founded | 1990 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Diversified Commercial Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1996 | 1996 |
| Metric | NKTR | UPBD |
|---|---|---|
| Price | $37.08 | $17.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 6 |
| Target Price | ★ $133.08 | $27.50 |
| AVG Volume (30 Days) | ★ 1.4M | 1.0M |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 8.98% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.98 |
| Revenue | $307,711,000.00 | ★ $4,695,061,000.00 |
| Revenue This Year | N/A | $0.81 |
| Revenue Next Year | $30.00 | $4.07 |
| P/E Ratio | ★ N/A | $17.74 |
| Revenue Growth | ★ 86.00 | 8.67 |
| 52 Week Low | $33.40 | $14.98 |
| 52 Week High | $109.00 | $23.98 |
| Indicator | NKTR | UPBD |
|---|---|---|
| Relative Strength Index (RSI) | 29.12 | 56.50 |
| Support Level | $34.45 | $17.00 |
| Resistance Level | $39.59 | $19.50 |
| Average True Range (ATR) | 1.98 | 0.57 |
| MACD | 0.66 | 0.28 |
| Stochastic Oscillator | 22.11 | 83.98 |
Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has four operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions, Mexico segment offers lease-to-own stores in Mexico. The The Brigit segment offers various financial health products and tools to help users improve their financial health. The company derives a majority of its revenue from the Acima segment.